Insider · CIK 0001230724
Andrew Guggenhime
cfopresidentofficerdirector
Files at CRBU (Caribou Biosciences, Inc.), PCVX (Vaxcyte, Inc.). First filing Oct 22, 2024, latest Feb 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $7.6M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCVX: Vaxcyte, Inc.
PCVXOct 9, 2026 · close 71.38
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Vaxcyte, Inc. | $671k 8,000 shares | -7% | - | |
| 8Weak | Vaxcyte, Inc. | $692k 8,000 shares | -7% | - | |
| 23Weak | Vaxcyte, Inc. | $710k 8,000 shares | -7% | - | |
| 23Weak | Vaxcyte, Inc. | $687k 8,000 shares | -7% | - | |
| 37Weak | Vaxcyte, Inc. | $4.8M 42,000 shares | -32% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -7,155 | $60.36 | $432k | 95,316 | 33 d ago |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,273 | $60.74 | $77k | 103,903 | 40 d ago |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,432 | $61.58 | $88k | 102,471 | 40 d ago |
| Mar 9, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,021 | $59.32 | $61k | 104,395 | Mar 11, 2026 |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +44,864 | $0.00 | $0 | 107,323 | Mar 2, 2026 |
| Feb 28, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -898 | $61.98 | $56k | 106,425 | Mar 2, 2026 |
| Mar 2, 2026 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,009 | $61.98 | $63k | 105,416 | Mar 2, 2026 |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +74,993 | $0.00 | $0 | 74,993 | Mar 2, 2026 |
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +45,000 | $0.00 | $0 | 45,000 | Feb 20, 2026 |
| Jan 14, 2026 | PCVX Vaxcyte, Inc. | GGift Common Stock | -61,850 | $0.00 | $0 | 62,459 | Jan 16, 2026 |
| Jan 14, 2026 | PCVX Vaxcyte, Inc. | GGift Common Stockindirect: See Footnote | +61,850 | $0.00 | $0 | 61,850 | Jan 16, 2026 |
| Sep 8, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -2,890 | $32.41 | $94k | 124,309 | Sep 10, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,270 | $31.56 | $40k | 131,009 | Sep 4, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -2,381 | $31.56 | $75k | 128,628 | Sep 4, 2025 |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,429 | $31.56 | $45k | 127,199 | Sep 4, 2025 |
| Apr 7, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock | +4,777 | $20.93 | $100k | 131,950 | Apr 9, 2025 |
| Apr 7, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative | -4,777 | $0.00 | $0 | 121,115 | Apr 9, 2025 |
| Feb 27, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +22,761 | $0.00 | $0 | 132,252 | Mar 3, 2025 |
| Feb 28, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -1,270 | $73.02 | $93k | 130,982 | Mar 3, 2025 |
| Mar 3, 2025 | PCVX Vaxcyte, Inc. | FTax withholding Common Stock | -3,809 | $72.10 | $275k | 127,173 | Mar 3, 2025 |
| Feb 27, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +75,991 | $0.00 | $0 | 75,991 | Mar 3, 2025 |
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +40,500 | $0.00 | $0 | 40,500 | Feb 21, 2025 |
| Feb 18, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 117,491 | Feb 19, 2025 |
| Feb 18, 2025 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -6,182 | $83.64 | $517k | 111,309 | Feb 19, 2025 |
| Feb 18, 2025 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,818 | $84.58 | $154k | 109,491 | Feb 19, 2025 |
| Feb 18, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 246,827 | Feb 19, 2025 |
| Jan 21, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 117,491 | Jan 22, 2025 |
| Jan 21, 2025 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -5,318 | $86.08 | $458k | 112,173 | Jan 22, 2025 |
| Jan 21, 2025 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,999 | $87.25 | $174k | 110,174 | Jan 22, 2025 |
| Jan 21, 2025 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -683 | $87.70 | $60k | 109,491 | Jan 22, 2025 |
| Jan 21, 2025 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 254,827 | Jan 22, 2025 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 117,491 | Dec 19, 2024 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,190 | $87.26 | $104k | 116,301 | Dec 19, 2024 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -3,373 | $88.70 | $299k | 112,928 | Dec 19, 2024 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -3,157 | $89.31 | $282k | 109,771 | Dec 19, 2024 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -280 | $90.24 | $25k | 109,491 | Dec 19, 2024 |
| Dec 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 262,827 | Dec 19, 2024 |
| Nov 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 117,491 | Nov 19, 2024 |
| Nov 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -6,111 | $85.60 | $523k | 111,380 | Nov 19, 2024 |
| Nov 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -1,757 | $86.49 | $152k | 109,623 | Nov 19, 2024 |
| Nov 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -132 | $87.05 | $11k | 109,491 | Nov 19, 2024 |
| Nov 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 270,827 | Nov 19, 2024 |
| Nov 7, 2024 | PCVX Vaxcyte, Inc. | AGrant or award Performance Stock Option (right to buy)derivative | +87,481 | $0.00 | $0 | 87,481 | Nov 8, 2024 |
| Nov 7, 2024 | PCVX Vaxcyte, Inc. | AGrant or award Performance Restricted Stock Unitsderivative | +35,661 | $0.00 | $0 | 35,661 | Nov 8, 2024 |
| Oct 25, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock | +19,108 | $20.93 | $400k | 109,491 | Oct 28, 2024 |
| Oct 25, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative | -19,108 | $0.00 | $0 | 125,892 | Oct 28, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 98,383 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +8,000 | $5.35 | $43k | 106,383 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +12,000 | $5.35 | $64k | 118,383 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Common Stock10b5-1 | +14,000 | $5.35 | $75k | 132,383 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -36,114 | $115.26 | $4.2M | 96,269 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | SOpen-market sale Common Stock10b5-1 | -5,886 | $116.19 | $684k | 90,383 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 312,827 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 304,827 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 292,827 | Oct 22, 2024 |
| Oct 18, 2024 | PCVX Vaxcyte, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -14,000 | $0.00 | $0 | 278,827 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.